HARVARD BIOSCIENCE INC

Regulatory Filings • Jun 13, 2025

UNITED S T A TES

SECURITIE S AND EXCHANGE COMMISSION

W ashington, D.C. 20549

---

FORM 8-K

---

CURRENT REPO R T

Pursuant to Section 13 or 15(d)

of the Securities E xchang e Act of 1934

Date of Report (Date of earliest e vent r eported): June 10, 2025

---

HARVARD BIOSCIENCE, INC.

(Exact name of reg i strant as specif i ed in its chart e r)

---

Delaware	001-33957	04-3306140
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

84 October Hill Road

Holliston , MA 01746

(Address of Principal Exe c utive O f fices) (Zip Code)

(508) 893-8999

(Registrant's t e lephone numbe r , including area code)

(Former name or former address, if c hanged since last report)

---

Check the appropria t e box below if the Form 8-K fil i ng is intended to simu l taneously satisfy t he filing obligat i on of the registrant under any of the following provisions:

☐ W ritten communications pursuant to R ule 425 under the Securi t ie s Act (17 CFR 230.425)

☐ Solici t ing material pursu a nt to Rule 14a-12 under the E xchang e Act (17 CFR 240.14a-12)

☐ Pre-commen c ement communi c ations pursuant to Rule 14d-2(b) under the Exchang e Act (17 C FR 240.14d-2(b))

☐ Pre-commen c ement communi c ations pursuant to Rule 13e-4(c) under the Exchang e Act (17 CFR 240.13e-4(c))

Securities reg i stered pursuant to Sec t ion 12(b) of th e Act:

| Title of each class | Trading Symbol(s) | Name of each exchange
on which registered |
| --- | --- | --- |
| Common Stock, $0.01 par
value | HBIO | The NASDAQ Stock Market |

Indicate by check m ark whether the regis t rant is an eme r ging growth company as defined in Rule 405 of the Securitie s A c t of 1933 (§230.405 of this chapter) or Rule 12b-2 of the S e curities Exchang e Act of 1934 (§240.12b-2 of this chapter).

Eme r ging growth company ☐

If an eme r ging growth compan y , indicate by check m ark if the registrant has elected not to use the extended t ransition period for comply i ng with any new or revised financial accounting stand a rds provided pursuant to Section 13(a) of the Exchange Act. ☐

Field: Page; Sequence: 1

Field: /Page

Item 5.02 Departu r e of Di r ectors or Certain Officers; Elect i on of Di r ectors ; Appointment of Certain O fficers; Compensator y Arrang e ments of Certain Officer s .

On June 10, 2025, Alan Edrick resigned from t he board of directors of Harvard Biosci e nce, Inc. (the “Company”), e f fective June 10, 2025. M r . Edrick ’ s resignation was not a result of any dis a greement or any ma t ter relating t o the Company ’ s operations, policies, or pract i ces.

Item 9.01 Financial Statements and Exh i bits.

(d) Exhibits.

Exhibit Number	Description
104	Cover Page Interac t ive Data File (embedded within
the XBRL document)

Field: Page; Sequence: 2

Field: /Page

SIGN A TURE

Pursuant to the require m ents of the Securit i es Exchang e Act of 1934, the registrant has duly c a used this report to be sign e d on its behalf by the undersigned hereunto duly authorized.

| | HA R V ARD BIOSCIENCE,
INC. |
| --- | --- |
| Date: June 13, 2025 | /s/ Mark Frost |
| | Mark Frost |
| | Interim Chief Financial Officer and Treasurer |

Field: Rule-Page

Field: /Rule-Page

Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjd0KwjAMhZ9g7xB6PVw7UGGXDh3iFBlDvC0uSnFrRlr/Hsm3tG6IIRCSc74cIWJR0Mq0yHBcVCXU2PWt9ggVnpHRnjA48vUmgzArvBjnWVs/rD8wp8BgYGYTeQr3wXk3DpsM5CxRaZJOQapMzWG/FdFXz8meTYPWG92Ctg3smXo26DW/xg+1fpKl7jUkHZCdIZuBmshRfkMqVQo7uusH8dVBWeYiioeKRMF064Nr+fRovyQsW+xCnBvpf0cfyilKWg==